Medtronic PLC has launched a multi-site trial in Europe to evaluate its Arctic Front Advance ablation cryoballoon as a first-line treatment for atrial fibrillation. The study is intended to find if earlier ablation can improve AF outcomes, since half of patients don't respond to standard drug therapy, Medtronic says.
The clinical trial called Cryo-FIRST will recruit up to 218 patients in about 12 sites across Europe, and randomize patients to the cryoballoon versus standard drug therapy to evaluate if...